XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.88

+0.2%

Nov 25 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (14601)	9/16/2000 3:41:46 PM
From: Cacaito	Read Replies (1) of 17367

Bpi chances in meningococcemia indication? yes, if a larger trail confirms what this one showed as a trend to decrease amputations. If xoma loves the kids, as much as you and blue, they could go ahead and do a 900 subjects $150M study with a clearcut goal to decrease amputations, to get the definite answer, like CORR did for adults in the angina study. xoma will not, they have better things to do with their money and the resulting drug will be less of a profit one, cause is an smaller indication,less money. I am not questioning you about that, I am asking xoma to do it.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next